The hybrid nature of the CXCR4 targeting imaging agent MSAP-Ac-TZ14011 has allowed us to successfully demonstrate the concept of integrating target selection in fresh (biopsy) tumor tissue with in vivo imaging and ex vivo microscopic validation (Fig. 1), all using a single imaging agent. The gene discussed is CXCR4; the disease is neoplasm.